MTNB
Matinas Biopharma·AMEX
--
--(--)
--
--(--)
MTNB fundamentals
Matinas Biopharma (MTNB) expects to report earnings on Apr 15, 2025, with estimated revenue of 0 (YoY 0.00%), and EPS at -0.78 (YoY +22.00%).
Revenue estimate / YoY
0
0.00%
EPS estimate / YoY
-0.78
+22.00%
Report date
Apr 15, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Matinas Biopharma (MTNB) key financial stats and ratios, covering profitability, financial health, and leverage.
Matinas Biopharma (MTNB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Matinas Biopharma (MTNB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Matinas Biopharma (MTNB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Matinas Biopharma (MTNB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Matinas Biopharma (MTNB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Matinas Biopharma year over year?What were the key takeaways from Matinas Biopharma's earnings call?What does Matinas Biopharma do and what are its main business segments?What factors drove the changes in Matinas Biopharma's revenue and profit?What is Matinas Biopharma's latest dividend and current dividend yield?Did Matinas Biopharma beat or miss consensus estimates last quarter?What were the key takeaways from Matinas Biopharma’s earnings call?What is the market's earnings forecast for Matinas Biopharma next quarter?
